-
2
-
-
84888161110
-
Disrupted nighttime sleep in narcolepsy
-
PID: 23997709
-
Roth T, Dauvilliers Y, Mignot E, Montplaisir J, Paul J, Swick T, et al. Disrupted nighttime sleep in narcolepsy. J Clin Sleep Med. 2013;9(9):955–65.
-
(2013)
J Clin Sleep Med
, vol.9
, Issue.9
, pp. 955-965
-
-
Roth, T.1
Dauvilliers, Y.2
Mignot, E.3
Montplaisir, J.4
Paul, J.5
Swick, T.6
-
3
-
-
0037086990
-
The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study
-
PID: 11902429
-
Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002;25(2):197–202.
-
(2002)
Sleep
, vol.25
, Issue.2
, pp. 197-202
-
-
Silber, M.H.1
Krahn, L.E.2
Olson, E.J.3
Pankratz, V.S.4
-
4
-
-
33846202929
-
The epidemiology of narcolepsy
-
PID: 17310860
-
Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep. 2007;30(1):13–26.
-
(2007)
Sleep
, vol.30
, Issue.1
, pp. 13-26
-
-
Longstreth, W.T.1
Koepsell, T.D.2
Ton, T.G.3
Hendrickson, A.F.4
van Belle, G.5
-
5
-
-
84874783317
-
ImmunoChip study implicates antigen presentation to T cells in narcolepsy
-
PID: 23459209, COI: 1:CAS:528:DC%2BC3sXkt1WltrY%3D
-
Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, Einen M, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013;9(2):e1003270.
-
(2013)
PLoS Genet
, vol.9
, Issue.2
, pp. e1003270
-
-
Faraco, J.1
Lin, L.2
Kornum, B.R.3
Kenny, E.E.4
Trynka, G.5
Einen, M.6
-
6
-
-
0034846670
-
Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy
-
PID: 11558795, COI: 1:CAS:528:DC%2BD3MXntFalt7s%3D
-
Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2001;50(3):381–8.
-
(2001)
Ann Neurol
, vol.50
, Issue.3
, pp. 381-388
-
-
Nishino, S.1
Ripley, B.2
Overeem, S.3
Nevsimalova, S.4
Lammers, G.J.5
Vankova, J.6
-
7
-
-
84892655928
-
-
De la Herrán-Arita AK et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci Transl Med. 2013;5:216ra176
-
De la Herrán-Arita AK et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci Transl Med. 2013;5:216ra176. doi:10.1126/scitranslmed.3007762
-
-
-
-
8
-
-
77954948437
-
Hypocretins in the control of sleep and wakefulness
-
PID: 20425032, COI: 1:CAS:528:DC%2BC3cXht1CjsL3E
-
Bonnavion P, de Lecea L. Hypocretins in the control of sleep and wakefulness. Curr Neurol Neurosci Rep. 2010;10(3):174–9.
-
(2010)
Curr Neurol Neurosci Rep
, vol.10
, Issue.3
, pp. 174-179
-
-
Bonnavion, P.1
de Lecea, L.2
-
9
-
-
84920198139
-
Orexin/hypocretin role in reward: implications for opioid and other addictions
-
Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, et al. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol. Epub 15 Feb 2014.
-
Br J Pharmacol. Epub
, pp. 15
-
-
Baimel, C.1
Bartlett, S.E.2
Chiou, L.C.3
Lawrence, A.J.4
Muschamp, J.W.5
Patkar, O.6
-
10
-
-
0035846568
-
Age at onset of narcolepsy in two large populations of patients in France and Quebec
-
PID: 11739821, COI: 1:STN:280:DC%2BD3Mnpt1Kjuw%3D%3D
-
Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, Besset A, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology. 2001;57(11):2029–33.
-
(2001)
Neurology
, vol.57
, Issue.11
, pp. 2029-2033
-
-
Dauvilliers, Y.1
Montplaisir, J.2
Molinari, N.3
Carlander, B.4
Ondze, B.5
Besset, A.6
-
11
-
-
0036467285
-
Clinical aspects of narcolepsy–cataplexy across ethnic groups
-
PID: 11833858
-
Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Clinical aspects of narcolepsy–cataplexy across ethnic groups. Sleep. 2002;25(1):27–35.
-
(2002)
Sleep
, vol.25
, Issue.1
, pp. 27-35
-
-
Okun, M.L.1
Lin, L.2
Pelin, Z.3
Hong, S.4
Mignot, E.5
-
12
-
-
84878361343
-
Genetic association, seasonal infections and autoimmune basis of narcolepsy
-
PID: 23497937, COI: 1:CAS:528:DC%2BC3sXktlGmu7c%3D
-
Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun. 2013;43:26–31.
-
(2013)
J Autoimmun
, vol.43
, pp. 26-31
-
-
Singh, A.K.1
Mahlios, J.2
Mignot, E.3
-
14
-
-
84890722534
-
Clinical and polysomnographic course of childhood narcolepsy with cataplexy
-
PID: 24142146
-
Pizza F, Franceschini C, Peltola H, Vandi S, Finotti E, Ingravallo F, et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain. 2013;136(Pt 12):3787–95.
-
(2013)
Brain
, vol.136
, pp. 3787-3795
-
-
Pizza, F.1
Franceschini, C.2
Peltola, H.3
Vandi, S.4
Finotti, E.5
Ingravallo, F.6
-
15
-
-
84873387056
-
High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy
-
PID: 23372264
-
Poli F, Pizza F, Mignot E, Ferri R, Pagotto U, Taheri S, et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep. 2013;36(2):175–81.
-
(2013)
Sleep
, vol.36
, Issue.2
, pp. 175-181
-
-
Poli, F.1
Pizza, F.2
Mignot, E.3
Ferri, R.4
Pagotto, U.5
Taheri, S.6
-
16
-
-
33745360679
-
Narcolepsy–cataplexy associated with precocious puberty
-
PID: 16717224, COI: 1:STN:280:DC%2BD283ovVKgsQ%3D%3D
-
Plazzi G, Parmeggiani A, Mignot E, Lin L, Scano MC, Posar A, et al. Narcolepsy–cataplexy associated with precocious puberty. Neurology. 2006;66(10):1577–9.
-
(2006)
Neurology
, vol.66
, Issue.10
, pp. 1577-1579
-
-
Plazzi, G.1
Parmeggiani, A.2
Mignot, E.3
Lin, L.4
Scano, M.C.5
Posar, A.6
-
17
-
-
84879007507
-
Impact of obesity in children with narcolepsy
-
PID: 23574649
-
Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin MP, et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther. 2013;19(7):521–8.
-
(2013)
CNS Neurosci Ther
, vol.19
, Issue.7
, pp. 521-528
-
-
Inocente, C.O.1
Lavault, S.2
Lecendreux, M.3
Dauvilliers, Y.4
Reimao, R.5
Gustin, M.P.6
-
18
-
-
1542471912
-
A putative link between childhood narcolepsy and obesity
-
PID: 15033134
-
Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med. 2004;5(2):147–50.
-
(2004)
Sleep Med
, vol.5
, Issue.2
, pp. 147-150
-
-
Kotagal, S.1
Krahn, L.E.2
Slocumb, N.3
-
19
-
-
77952122423
-
Childhood-onset narcolepsy, obesity and puberty in four consecutive children: a close temporal link
-
PID: 20480724
-
Perriol MP, Cartigny M, Lamblin MD, Poirot I, Weill J, Derambure P, et al. Childhood-onset narcolepsy, obesity and puberty in four consecutive children: a close temporal link. J Pediatr Endocrinol Metab. 2010;23(3):257–65.
-
(2010)
J Pediatr Endocrinol Metab
, vol.23
, Issue.3
, pp. 257-265
-
-
Perriol, M.P.1
Cartigny, M.2
Lamblin, M.D.3
Poirot, I.4
Weill, J.5
Derambure, P.6
-
20
-
-
78649896476
-
Clinical and therapeutic aspects of childhood narcolepsy–cataplexy: a retrospective study of 51 children
-
PID: 21102987
-
Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy–cataplexy: a retrospective study of 51 children. Sleep. 2010;33(11):1457–64.
-
(2010)
Sleep
, vol.33
, Issue.11
, pp. 1457-1464
-
-
Aran, A.1
Einen, M.2
Lin, L.3
Plazzi, G.4
Nishino, S.5
Mignot, E.6
-
22
-
-
84891630436
-
Narcolepsy–cataplexy and schizophrenia in adolescents
-
PID: 24268496
-
Huang YS, Guilleminault C, Chen CH, Lai PC, Hwang FM. Narcolepsy–cataplexy and schizophrenia in adolescents. Sleep Med. 2014;15(1):15–22.
-
(2014)
Sleep Med
, vol.15
, Issue.1
, pp. 15-22
-
-
Huang, Y.S.1
Guilleminault, C.2
Chen, C.H.3
Lai, P.C.4
Hwang, F.M.5
-
23
-
-
79851506224
-
Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy
-
PID: 21173745
-
Sonka K, Kemlink D, Buskova J, Pretl M, Srutkova Z, Maurovich Horvat E, et al. Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy. Neuro Endocrinol Lett. 2010;31(5):631–4.
-
(2010)
Neuro Endocrinol Lett
, vol.31
, Issue.5
, pp. 631-634
-
-
Sonka, K.1
Kemlink, D.2
Buskova, J.3
Pretl, M.4
Srutkova, Z.5
Maurovich Horvat, E.6
-
24
-
-
33750130178
-
The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin
-
PID: 17015503
-
Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics. 2006;118(4):e1116–23.
-
(2006)
Pediatrics
, vol.118
, Issue.4
, pp. e1116-e1123
-
-
Stores, G.1
Montgomery, P.2
Wiggs, L.3
-
25
-
-
58149286309
-
Psychosocial and intellectual functioning in childhood narcolepsy
-
PID: 18608355
-
Dorris L, Zuberi SM, Scott N, Moffat C, McArthur I. Psychosocial and intellectual functioning in childhood narcolepsy. Dev Neurorehabil. 2008;11(3):187–94.
-
(2008)
Dev Neurorehabil
, vol.11
, Issue.3
, pp. 187-194
-
-
Dorris, L.1
Zuberi, S.M.2
Scott, N.3
Moffat, C.4
McArthur, I.5
-
26
-
-
78650290253
-
Clinical, polysomnographic and laboratory characteristics of narcolepsy–cataplexy in a sample of children and adolescents
-
PID: 21050810
-
Peraita-Adrados R, Garcia-Penas JJ, Ruiz-Falco L, Gutierrez-Solana L, Lopez-Esteban P, Vicario JL, et al. Clinical, polysomnographic and laboratory characteristics of narcolepsy–cataplexy in a sample of children and adolescents. Sleep Med. 2011;12(1):24–7.
-
(2011)
Sleep Med
, vol.12
, Issue.1
, pp. 24-27
-
-
Peraita-Adrados, R.1
Garcia-Penas, J.J.2
Ruiz-Falco, L.3
Gutierrez-Solana, L.4
Lopez-Esteban, P.5
Vicario, J.L.6
-
27
-
-
84895474066
-
Depressive feelings in children with narcolepsy
-
PID: 24503472
-
Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, et al. Depressive feelings in children with narcolepsy. Sleep Med. 2014;15(3):309–14.
-
(2014)
Sleep Med
, vol.15
, Issue.3
, pp. 309-314
-
-
Inocente, C.O.1
Gustin, M.P.2
Lavault, S.3
Guignard-Perret, A.4
Raoux, A.5
Christol, N.6
-
28
-
-
84893371346
-
Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population
-
PID: 23643648
-
Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 2013;14(6):488–92.
-
(2013)
Sleep Med
, vol.14
, Issue.6
, pp. 488-492
-
-
Ohayon, M.M.1
-
29
-
-
84900002785
-
Delayed diagnosis of narcolepsy: characterization and impact
-
PID: 24780133
-
Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15:502–7.
-
(2014)
Sleep Med
, vol.15
, pp. 502-507
-
-
Thorpy, M.J.1
Krieger, A.C.2
-
30
-
-
67650447016
-
The economic consequences of narcolepsy
-
PID: 19960645
-
Jennum P, Knudsen S, Kjellberg J. The economic consequences of narcolepsy. J Clin Sleep Med. 2009;5(3):240–5.
-
(2009)
J Clin Sleep Med
, vol.5
, Issue.3
, pp. 240-245
-
-
Jennum, P.1
Knudsen, S.2
Kjellberg, J.3
-
31
-
-
84904687579
-
-
Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, et al. Quality of life in children with narcolepsy. CNS Neurosci Ther. 2014. [Epub ahead of print]
-
Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, et al. Quality of life in children with narcolepsy. CNS Neurosci Ther. 2014. [Epub ahead of print].
-
-
-
-
32
-
-
84901785541
-
Quality of life in children with narcolepsy and cataplexy
-
Lecendreux M. Quality of life in children with narcolepsy and cataplexy. Sleep Med Clin. 2014;9:211–7
-
(2014)
Sleep Med Clin.
, vol.9
, pp. 211-217
-
-
Lecendreux, M.1
-
33
-
-
9644288106
-
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset
-
PID: 15562415, COI: 1:CAS:528:DC%2BD2MXit1CgtQ%3D%3D
-
Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004;56(6):905–8.
-
(2004)
Ann Neurol
, vol.56
, Issue.6
, pp. 905-908
-
-
Dauvilliers, Y.1
Carlander, B.2
Rivier, F.3
Touchon, J.4
Tafti, M.5
-
34
-
-
56349137577
-
Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy
-
PID: 18769859
-
Plazzi G, Poli F, Franceschini C, Parmeggiani A, Pirazzoli P, Bernardi F, et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol. 2008;255(10):1549–54.
-
(2008)
J Neurol
, vol.255
, Issue.10
, pp. 1549-1554
-
-
Plazzi, G.1
Poli, F.2
Franceschini, C.3
Parmeggiani, A.4
Pirazzoli, P.5
Bernardi, F.6
-
35
-
-
39149117391
-
Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function
-
PID: 18295156
-
Vitiello B. Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. Child Adolesc Psychiatr Clin N Am. 2008;17(2):459–74.
-
(2008)
Child Adolesc Psychiatr Clin N Am
, vol.17
, Issue.2
, pp. 459-474
-
-
Vitiello, B.1
-
36
-
-
34547680517
-
A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents
-
PID: 19300563, COI: 1:CAS:528:DC%2BD2sXps1Wns7Y%3D
-
Rugino T. A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat. 2007;3(3):293–301.
-
(2007)
Neuropsychiatr Dis Treat
, vol.3
, Issue.3
, pp. 293-301
-
-
Rugino, T.1
-
37
-
-
85099638235
-
-
Cephalon: Inc.
-
® [modafinil] tablets US prescribing information. Frazer: Cephalon, Inc.; 2010.
-
(2010)
Frazer
-
-
-
38
-
-
85099639095
-
-
Cephalon: Inc.
-
® [armodafinil] tablets US prescribing information. Frazer: Cephalon, Inc.; 2010.
-
(2010)
Frazer
-
-
-
39
-
-
0032931432
-
Critical review of tricyclic antidepressant use in children and adolescents
-
PID: 10230182, COI: 1:STN:280:DyaK1M3ks1OqtQ%3D%3D
-
Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(5):513–6.
-
(1999)
J Am Acad Child Adolesc Psychiatry
, vol.38
, Issue.5
, pp. 513-516
-
-
Geller, B.1
Reising, D.2
Leonard, H.L.3
Riddle, M.A.4
Walsh, B.T.5
-
40
-
-
33748946763
-
EFNS guidelines on management of narcolepsy
-
PID: 16987156, COI: 1:STN:280:DC%2BD28rmt1Sgsw%3D%3D
-
Billiard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers GJ, Mayer G, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol. 2006;13(10):1035–48.
-
(2006)
Eur J Neurol
, vol.13
, Issue.10
, pp. 1035-1048
-
-
Billiard, M.1
Bassetti, C.2
Dauvilliers, Y.3
Dolenc-Groselj, L.4
Lammers, G.J.5
Mayer, G.6
-
41
-
-
36849065939
-
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin
-
PID: 18246980
-
Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705–11.
-
(2007)
Sleep
, vol.30
, Issue.12
, pp. 1705-1711
-
-
Morgenthaler, T.I.1
Kapur, V.K.2
Brown, T.3
Swick, T.J.4
Alessi, C.5
Aurora, R.N.6
-
42
-
-
84883346377
-
Narcolepsy: diagnosis and management
-
Kryger MH, Roth T, Dement WC, (eds), Elsevier, St. Louis:
-
Guilleminault C, Fromherz S. Narcolepsy: diagnosis and management. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 5th ed. St. Louis: Elsevier; 2011.
-
(2011)
Principles and practice of sleep medicine
-
-
Guilleminault, C.1
Fromherz, S.2
-
43
-
-
84868013057
-
A practical guide to the therapy of narcolepsy and hypersomnia syndromes
-
PID: 23065655
-
Mignot EJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9(4):739–52.
-
(2012)
Neurotherapeutics
, vol.9
, Issue.4
, pp. 739-752
-
-
Mignot, E.J.1
-
44
-
-
84876815800
-
Pediatric narcolepsy: clinical and therapeutical approaches
-
Lecendreux M. Pediatric narcolepsy: clinical and therapeutical approaches. Handb Clin Neurol. 2013;112:839–45.
-
(2013)
Handb Clin Neurol
, vol.112
, pp. 839-845
-
-
Lecendreux, M.1
-
45
-
-
0342545934
-
US Modafinil in Narcolepsy Multicenter Study Group
-
Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology. 2000;54(5):1166–75.
-
(2000)
Neurology
, vol.54
, Issue.5
, pp. 1166-1175
-
-
-
46
-
-
33646267923
-
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy
-
PID: 16684437, COI: 1:CAS:528:DC%2BD28XlsFWksLY%3D
-
Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin. 2006;22(4):761–74.
-
(2006)
Curr Med Res Opin
, vol.22
, Issue.4
, pp. 761-774
-
-
Harsh, J.R.1
Hayduk, R.2
Rosenberg, R.3
Wesnes, K.A.4
Walsh, J.K.5
Arora, S.6
-
47
-
-
33745728203
-
Sodium oxybate improves excessive daytime sleepiness in narcolepsy
-
PID: 16895262
-
Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep. 2006;29(7):939–46.
-
(2006)
Sleep
, vol.29
, Issue.7
, pp. 939-946
-
-
Black, J.1
Houghton, W.C.2
-
48
-
-
0742271698
-
Modafinil in the treatment of excessive daytime sleepiness in children
-
PID: 14607353
-
Ivanenko A, Tauman R, Gozal D. Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med. 2003;4(6):579–82.
-
(2003)
Sleep Med
, vol.4
, Issue.6
, pp. 579-582
-
-
Ivanenko, A.1
Tauman, R.2
Gozal, D.3
-
49
-
-
84892868808
-
Modafinil is well tolerated in children and adolescents with excessive sleepiness and obstructive sleep apnea: a 6- week double blind study [abstract]
-
Owens J, Bogan R, Lankford A, Sheldon S. Modafinil is well tolerated in children and adolescents with excessive sleepiness and obstructive sleep apnea: a 6- week double blind study [abstract]. Sleep. 2007;30(Suppl):A88–9.
-
(2007)
Sleep
, vol.30
, pp. A88-A89
-
-
Owens, J.1
Bogan, R.2
Lankford, A.3
Sheldon, S.4
-
50
-
-
84863774625
-
Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy
-
PID: 22283810
-
Lecendreux M, Bruni O, Franco P, Gringras P, Konofal E, Nevsimalova S, et al. Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy. J Sleep Res. 2012;21(4):481–3.
-
(2012)
J Sleep Res
, vol.21
, Issue.4
, pp. 481-483
-
-
Lecendreux, M.1
Bruni, O.2
Franco, P.3
Gringras, P.4
Konofal, E.5
Nevsimalova, S.6
-
51
-
-
12144291325
-
Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy
-
Xyrem US, Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 2004;5(2):119–23.
-
(2004)
Sleep Med
, vol.5
, Issue.2
, pp. 119-123
-
-
Xyrem, U.S.1
Multicenter Study Group2
-
52
-
-
24344500187
-
Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients
-
Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med. 2005;6(5):415–21.
-
(2005)
Sleep Med.
, vol.6
, Issue.5
, pp. 415-421
-
-
Xyrem International Study Group1
-
53
-
-
33747517239
-
Off-label treatment of severe childhood narcolepsy–cataplexy with sodium oxybate
-
PID: 16944670
-
Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsy–cataplexy with sodium oxybate. Sleep. 2006;29(8):1025–9.
-
(2006)
Sleep
, vol.29
, Issue.8
, pp. 1025-1029
-
-
Murali, H.1
Kotagal, S.2
-
54
-
-
84860609389
-
Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study
-
PID: 22547897
-
Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CE, Franceschini C, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep. 2012;35(5):709–11.
-
(2012)
Sleep
, vol.35
, Issue.5
, pp. 709-711
-
-
Lecendreux, M.1
Poli, F.2
Oudiette, D.3
Benazzouz, F.4
Donjacour, C.E.5
Franceschini, C.6
-
55
-
-
84906766206
-
Time to response with sodium oxybate for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients with narcolepsy [APSS 2014 Abstract 0667]
-
Bogan RK, Roth T, Schwartz J, Miloslavsky M, Scharf M. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients with narcolepsy [APSS 2014 Abstract 0667]. Sleep. 2014;37(suppl):A233.
-
(2014)
Sleep
, vol.37
, pp. A233
-
-
Bogan, R.K.1
Roth, T.2
Schwartz, J.3
Miloslavsky, M.4
Scharf, M.5
-
56
-
-
84883786938
-
A retrospective survey of childhood ADHD symptomatology among adult narcoleptics
-
PID: 23548870
-
Modestino EJ, Winchester J. A retrospective survey of childhood ADHD symptomatology among adult narcoleptics. J Atten Disord. 2013;17(7):574–82.
-
(2013)
J Atten Disord
, vol.17
, Issue.7
, pp. 574-582
-
-
Modestino, E.J.1
Winchester, J.2
-
57
-
-
0030775911
-
Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat
-
PID: 9353396, COI: 1:CAS:528:DyaK2sXnsV2msLY%3D
-
Edgar DM, Seidel WF. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther. 1997;283(2):757–69.
-
(1997)
J Pharmacol Exp Ther
, vol.283
, Issue.2
, pp. 757-769
-
-
Edgar, D.M.1
Seidel, W.F.2
-
58
-
-
70649099211
-
The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents
-
PID: 19928382
-
Gruner JA, Marcy VR, Lin YG, Bozyczko-Coyne D, Marino MJ, Gasior M. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep. 2009;32(11):1425–38.
-
(2009)
Sleep
, vol.32
, Issue.11
, pp. 1425-1438
-
-
Gruner, J.A.1
Marcy, V.R.2
Lin, Y.G.3
Bozyczko-Coyne, D.4
Marino, M.J.5
Gasior, M.6
-
59
-
-
77955139288
-
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
-
PID: 20628632, COI: 1:CAS:528:DC%2BC3cXntlaqsrw%3D
-
Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6:317–27.
-
(2010)
Neuropsychiatr Dis Treat
, vol.6
, pp. 317-327
-
-
Pennick, M.1
-
60
-
-
67650225546
-
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
-
PID: 19508731
-
Wigal SB, Kollins SH, Childress AC, Squires L. A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health. 2009;3(1):17.
-
(2009)
Child Adolesc Psychiatry Ment Health
, vol.3
, Issue.1
, pp. 17
-
-
Wigal, S.B.1
Kollins, S.H.2
Childress, A.C.3
Squires, L.4
-
61
-
-
77955140309
-
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
-
PID: 20576091
-
Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010;6:34.
-
(2010)
Behav Brain Funct
, vol.6
, pp. 34
-
-
Wigal, T.1
Brams, M.2
Gasior, M.3
Gao, J.4
Squires, L.5
Giblin, J.6
-
62
-
-
34247257281
-
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
-
PID: 17577466, COI: 1:CAS:528:DC%2BD2sXlt1Gkurw%3D
-
Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450–63.
-
(2007)
Clin Ther
, vol.29
, Issue.3
, pp. 450-463
-
-
Biederman, J.1
Krishnan, S.2
Zhang, Y.3
McGough, J.J.4
Findling, R.L.5
-
63
-
-
79952967310
-
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder
-
PID: 21421179
-
Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell MC, et al. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(4):395–405.
-
(2011)
J Am Acad Child Adolesc Psychiatry
, vol.50
, Issue.4
, pp. 395-405
-
-
Findling, R.L.1
Childress, A.C.2
Cutler, A.J.3
Gasior, M.4
Hamdani, M.5
Ferreira-Cornwell, M.C.6
-
64
-
-
52649161328
-
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
-
PID: 19012818, COI: 1:CAS:528:DC%2BD1cXht1Cmt7nO
-
Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(9):1364–73.
-
(2008)
J Clin Psychiatry
, vol.69
, Issue.9
, pp. 1364-1373
-
-
Adler, L.A.1
Goodman, D.W.2
Kollins, S.H.3
Weisler, R.H.4
Krishnan, S.5
Zhang, Y.6
-
65
-
-
84884288612
-
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
-
PID: 23332456, COI: 1:CAS:528:DC%2BC3sXosFOksQ%3D%3D
-
Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, et al. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol. 2013;23(10):1208–18.
-
(2013)
Eur Neuropsychopharmacol
, vol.23
, Issue.10
, pp. 1208-1218
-
-
Coghill, D.1
Banaschewski, T.2
Lecendreux, M.3
Soutullo, C.4
Johnson, M.5
Zuddas, A.6
-
66
-
-
79951965205
-
Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls
-
PID: 21148631, COI: 1:CAS:528:DC%2BC3MXjslKjtLk%3D
-
Donjacour CE, Aziz NA, Frolich M, Roelfsema F, Overeem S, Lammers GJ, et al. Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls. Eur J Endocrinol. 2011;164(3):363–70.
-
(2011)
Eur J Endocrinol
, vol.164
, Issue.3
, pp. 363-370
-
-
Donjacour, C.E.1
Aziz, N.A.2
Frolich, M.3
Roelfsema, F.4
Overeem, S.5
Lammers, G.J.6
-
67
-
-
79957662618
-
Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls
-
PID: 21447786, COI: 1:CAS:528:DC%2BC3MXot1CnsrY%3D
-
Donjacour CE, Aziz NA, Roelfsema F, Frolich M, Overeem S, Lammers GJ, et al. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab. 2011;300(6):E1069–75.
-
(2011)
Am J Physiol Endocrinol Metab
, vol.300
, Issue.6
, pp. E1069-E1075
-
-
Donjacour, C.E.1
Aziz, N.A.2
Roelfsema, F.3
Frolich, M.4
Overeem, S.5
Lammers, G.J.6
-
69
-
-
0025775406
-
Mazindol in long-term treatment of narcolepsy
-
PID: 1674093, COI: 1:STN:280:DyaK3M3is1eiuw%3D%3D
-
Alvarez B, Dahlitz M, Grimshaw J, Parkes JD. Mazindol in long-term treatment of narcolepsy. Lancet. 1991;337(8752):1293–4.
-
(1991)
Lancet
, vol.337
, Issue.8752
, pp. 1293-1294
-
-
Alvarez, B.1
Dahlitz, M.2
Grimshaw, J.3
Parkes, J.D.4
-
70
-
-
84872339899
-
Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review
-
PID: 23036267
-
Nittur N, Konofal E, Dauvilliers Y, Franco P, Leu-Semenescu S, Cock VC, et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med. 2013;14(1):30–6.
-
(2013)
Sleep Med
, vol.14
, Issue.1
, pp. 30-36
-
-
Nittur, N.1
Konofal, E.2
Dauvilliers, Y.3
Franco, P.4
Leu-Semenescu, S.5
Cock, V.C.6
-
71
-
-
65249166541
-
Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations
-
PID: 19364297
-
Moller LR, Ostergaard JR. Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations. J Child Adolesc Psychopharmacol. 2009;19(2):197–201.
-
(2009)
J Child Adolesc Psychopharmacol
, vol.19
, Issue.2
, pp. 197-201
-
-
Moller, L.R.1
Ostergaard, J.R.2
-
72
-
-
84890395142
-
Treatment of cataplexy in a three-year-old using venlafaxine
-
PID: 24340297
-
Ratkiewicz M, Splaingard M. Treatment of cataplexy in a three-year-old using venlafaxine. J Clin Sleep Med. 2013;9(12):1341–2.
-
(2013)
J Clin Sleep Med
, vol.9
, Issue.12
, pp. 1341-1342
-
-
Ratkiewicz, M.1
Splaingard, M.2
-
73
-
-
0346887119
-
Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy
-
PID: 14633248
-
Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res. 2003;12(4):347–8.
-
(2003)
J Sleep Res
, vol.12
, Issue.4
, pp. 347-348
-
-
Lecendreux, M.1
Maret, S.2
Bassetti, C.3
Mouren, M.C.4
Tafti, M.5
-
74
-
-
78650969835
-
Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy
-
PID: 21210337, COI: 1:CAS:528:DC%2BC3MXjsFOhs7k%3D
-
Knudsen S, Mikkelsen JD, Bang B, Gammeltoft S, Jennum PJ. Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy. Neuropediatrics. 2010;41(5):217–22.
-
(2010)
Neuropediatrics
, vol.41
, Issue.5
, pp. 217-222
-
-
Knudsen, S.1
Mikkelsen, J.D.2
Bang, B.3
Gammeltoft, S.4
Jennum, P.J.5
-
75
-
-
36348966603
-
Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy
-
PID: 17762946
-
Fronczek R, Verschuuren J, Lammers GJ. Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol. 2007;254(11):1607–8.
-
(2007)
J Neurol
, vol.254
, Issue.11
, pp. 1607-1608
-
-
Fronczek, R.1
Verschuuren, J.2
Lammers, G.J.3
-
76
-
-
67349139579
-
No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy
-
PID: 18825431
-
Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol. 2008;255(12):1900–3.
-
(2008)
J Neurol
, vol.255
, Issue.12
, pp. 1900-1903
-
-
Valko, P.O.1
Khatami, R.2
Baumann, C.R.3
Bassetti, C.L.4
-
77
-
-
72249099225
-
Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment
-
PID: 19841387, COI: 1:STN:280:DC%2BD1Mjgt1ymsw%3D%3D
-
Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology. 2009;73(16):1333–4.
-
(2009)
Neurology
, vol.73
, Issue.16
, pp. 1333-1334
-
-
Dauvilliers, Y.1
Abril, B.2
Mas, E.3
Michel, F.4
Tafti, M.5
-
78
-
-
84863591736
-
Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency
-
PID: 22722630
-
Knudsen S, Biering-Sorensen B, Kornum BR, Petersen ER, Ibsen JD, Gammeltoft S, et al. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency. Neurology. 2012;79(1):102–3.
-
(2012)
Neurology
, vol.79
, Issue.1
, pp. 102-103
-
-
Knudsen, S.1
Biering-Sorensen, B.2
Kornum, B.R.3
Petersen, E.R.4
Ibsen, J.D.5
Gammeltoft, S.6
-
79
-
-
33845904178
-
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology
-
PID: 17005916, COI: 1:CAS:528:DC%2BD2sXjsFChsA%3D%3D
-
Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, et al. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther. 2007;320(1):365–75.
-
(2007)
J Pharmacol Exp Ther
, vol.320
, Issue.1
, pp. 365-375
-
-
Ligneau, X.1
Perrin, D.2
Landais, L.3
Camelin, J.C.4
Calmels, T.P.5
Berrebi-Bertrand, I.6
-
80
-
-
33947161911
-
The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders
-
PID: 17288995, COI: 1:CAS:528:DC%2BD2sXjt1Smtrw%3D
-
Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, et al. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol. 2007;73(8):1157–71.
-
(2007)
Biochem Pharmacol
, vol.73
, Issue.8
, pp. 1157-1171
-
-
Parmentier, R.1
Anaclet, C.2
Guhennec, C.3
Brousseau, E.4
Bricout, D.5
Giboulot, T.6
-
81
-
-
79958026433
-
The histamine H3 receptor: from discovery to clinical trials with pitolisant
-
PID: 21615387, COI: 1:CAS:528:DC%2BC3MXnsFOitr0%3D
-
Schwartz JC. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol. 2011;163(4):713–21.
-
(2011)
Br J Pharmacol
, vol.163
, Issue.4
, pp. 713-721
-
-
Schwartz, J.C.1
-
82
-
-
40849137722
-
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patients
-
PID: 18295497
-
Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patients. Neurobiol Dis. 2008;30(1):74–83.
-
(2008)
Neurobiol Dis
, vol.30
, Issue.1
, pp. 74-83
-
-
Lin, J.S.1
Dauvilliers, Y.2
Arnulf, I.3
Bastuji, H.4
Anaclet, C.5
Parmentier, R.6
-
83
-
-
0033588184
-
Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation
-
PID: 10481909, COI: 1:CAS:528:DyaK1MXlslWmsbo%3D
-
Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98(4):437–51.
-
(1999)
Cell
, vol.98
, Issue.4
, pp. 437-451
-
-
Chemelli, R.M.1
Willie, J.T.2
Sinton, C.M.3
Elmquist, J.K.4
Scammell, T.5
Lee, C.6
-
84
-
-
84885378478
-
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
-
PID: 24107292, COI: 1:CAS:528:DC%2BC3sXhsFyrsbjF
-
Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 2013;12(11):1068–75.
-
(2013)
Lancet Neurol
, vol.12
, Issue.11
, pp. 1068-1075
-
-
Dauvilliers, Y.1
Bassetti, C.2
Lammers, G.J.3
Arnulf, I.4
Mayer, G.5
Rodenbeck, A.6
-
85
-
-
84862791691
-
Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy–cataplexy in teenagers with refractory sleepiness
-
PID: 22356925, COI: 1:CAS:528:DC%2BC38XktV2hur0%3D
-
Inocente C, Arnulf I, Bastuji H, Thibault-Stoll A, Raoux A, Reimao R, et al. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy–cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol. 2012;35(2):55–60.
-
(2012)
Clin Neuropharmacol
, vol.35
, Issue.2
, pp. 55-60
-
-
Inocente, C.1
Arnulf, I.2
Bastuji, H.3
Thibault-Stoll, A.4
Raoux, A.5
Reimao, R.6
-
86
-
-
84859899795
-
Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
-
PID: 22036605, COI: 1:STN:280:DC%2BC38%2Fks1Wjtg%3D%3D
-
Baier PC, Hallschmid M, Seeck-Hirschner M, Weinhold SL, Burkert S, Diessner N, et al. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med. 2011;12(10):941–6.
-
(2011)
Sleep Med
, vol.12
, Issue.10
, pp. 941-946
-
-
Baier, P.C.1
Hallschmid, M.2
Seeck-Hirschner, M.3
Weinhold, S.L.4
Burkert, S.5
Diessner, N.6
-
87
-
-
84892516058
-
The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy
-
PID: 24406723, COI: 1:CAS:528:DC%2BC2cXisFehsbY%3D
-
Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Goder R, Baier PC. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res. 2014;262:8–13.
-
(2014)
Behav Brain Res
, vol.262
, pp. 8-13
-
-
Weinhold, S.L.1
Seeck-Hirschner, M.2
Nowak, A.3
Hallschmid, M.4
Goder, R.5
Baier, P.C.6
|